Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	84.51B
Revenue (ttm)	20.87B
Net Income (ttm)	4.62B
Shares Out	103.44M
EPS (ttm)	41.50
PE Ratio	15.34
Forward PE	19.11
Dividend	14.00 (1.68%)
Ex-Dividend Date	Jun 20, 2025

Volume	599,945
Average Volume	1,064,123
Open	821.00
Previous Close	817.00
Day's Range	818.00 - 829.00
52-Week Range	562.00 - 922.00
Beta	0.61
RSI	50.01
Earnings Date	Aug 11, 2025

About CALT

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.

Financial numbers in EUR